Fresenius Medical Care AG KGaA Comprehensive Income 2010-2024 | FMS

Fresenius Medical Care AG KGaA comprehensive income from 2010 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
  • Fresenius Medical Care AG KGaA comprehensive income for the quarter ending June 30, 2024 was $-0.668B, a 21.39% decline year-over-year.
  • Fresenius Medical Care AG KGaA comprehensive income for 2023 was $-1.055B, a 157.87% increase from 2022.
  • Fresenius Medical Care AG KGaA comprehensive income for 2022 was $-0.409B, a 73.62% decline from 2021.
  • Fresenius Medical Care AG KGaA comprehensive income for 2021 was $-1.552B, a 38.4% decline from 2020.
Fresenius Medical Care AG KGaA Annual Comprehensive Income
(Millions of US $)
2023 $-1,055
2022 $-409
2021 $-1,552
2020 $-2,519
2019 $-1,163
2018 $-1,422
2017 $-1,679
2016 $-1,319
2015 $-1,336
2014 $-1,088
2013 $
2012 $
2011 $
2010 $
2009 $
Fresenius Medical Care AG KGaA Quarterly Comprehensive Income
(Millions of US $)
2024-06-30 $-668
2024-03-31 $-867
2023-12-31 $-1,055
2023-09-30 $-462
2023-06-30 $-850
2023-03-31 $-732
2022-12-31 $-409
2022-09-30 $925
2022-06-30 $36
2022-03-31 $-1,097
2021-12-31 $-1,552
2021-09-30 $-1,788
2021-06-30 $-2,215
2021-03-31 $-2,028
2020-12-31 $-2,519
2020-09-30 $-2,014
2020-06-30 $-1,223
2020-03-31 $-1,049
2019-12-31 $-1,163
2019-09-30 $-683
2019-06-30 $-1,225
2019-03-31 $-1,086
2018-12-31 $-1,422
2018-09-30 $-1,556
2018-06-30 $-1,638
2018-03-31 $-2,112
2017-12-31 $-1,679
2017-09-30 $-1,523
2017-06-30 $-1,096
2017-03-31 $-391
2016-12-31 $-1,319
2016-09-30 $-1,176
2016-06-30 $-1,205
2016-03-31 $-1,226
2015-12-31 $-1,336
2015-09-30 $-1,288
2015-06-30 $-1,163
2015-03-31 $-1,201
2014-12-31 $-1,088
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $12.552B $21.053B
Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products..
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $209.197B 25.52
Intuitive Surgical (ISRG) United States $190.823B 99.77
Alcon (ALC) Switzerland $45.517B 32.04
IQVIA Holdings (IQV) United States $39.384B 21.70
Edwards Lifesciences (EW) United States $39.340B 24.98
IDEXX Laboratories (IDXX) United States $35.808B 42.17
DexCom (DXCM) United States $27.463B 41.36
Waters (WAT) United States $22.607B 33.43
SONOVA HOLDING (SONVY) Switzerland $22.062B 0.00
STERIS (STE) Ireland $21.899B 25.21
Hologic (HOLX) United States $18.440B 19.46
Sysmex ADR (SSMXY) Japan $12.915B 40.50
Globus Medical (GMED) United States $11.102B 28.27
Penumbra (PEN) United States $9.290B 91.00
Teleflex (TFX) United States $9.197B 14.67
Masimo (MASI) United States $8.654B 41.87
Glaukos (GKOS) United States $7.887B 0.00
PROCEPT BioRobotics (PRCT) United States $5.083B 0.00
Integer Holdings (ITGR) United States $4.679B 26.52
Inari Medical (NARI) United States $3.123B 0.00
Veracyte (VCYT) United States $3.014B 90.44
TransMedics (TMDX) United States $2.991B 94.80
LivaNova (LIVN) United Kingdom $2.813B 16.24
Nihon Kohden (NHNKY) Japan $2.554B 19.40
Elekta AB (EKTAY) Sweden $2.304B 18.77
Tandem Diabetes Care (TNDM) United States $2.060B 0.00
Integra LifeSciences Holdings (IART) United States $1.964B 10.26
RxSight (RXST) United States $1.867B 0.00
Alphatec Holdings (ATEC) United States $1.375B 0.00
Artivion (AORT) United States $1.210B 80.19
Pulse Biosciences (PLSE) United States $1.155B 0.00
OPKO Health (OPK) United States $1.072B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.951B 16.16
ORTHOFIX MEDICAL INC (OFIX) United States $0.764B 0.00
IRadimed (IRMD) United States $0.727B 39.28
Pacific Biosciences Of California (PACB) United States $0.670B 0.00
SiBone (SIBN) United States $0.664B 0.00
Mesa Laboratories (MLAB) United States $0.646B 15.23
Paragon 28 (FNA) United States $0.637B 0.00
AxoGen (AXGN) United States $0.615B 0.00
OrthoPediatrics (KIDS) United States $0.605B 0.00
Treace Medical Concepts (TMCI) United States $0.516B 0.00
CVRx (CVRX) United States $0.384B 0.00
Tactile Systems Technology (TCMD) United States $0.383B 20.73
Semler Scientific (SMLR) United States $0.379B 25.43
Delcath Systems (DCTH) United States $0.318B 0.00
ClearPoint Neuro (CLPT) United States $0.315B 0.00
AngioDynamics (ANGO) United States $0.302B 0.00
Inogen (INGN) United States $0.262B 0.00
Sight Sciences (SGHT) United States $0.233B 0.00
NeuroPace (NPCE) United States $0.213B 0.00
Atossa Genetics (ATOS) United States $0.204B 0.00
Accuray (ARAY) United States $0.199B 0.00
Nevro (NVRO) United States $0.198B 0.00
Alpha Tau Medical (DRTS) Israel $0.157B 0.00
KORU Medical Systems (KRMD) United States $0.132B 0.00
908 Devices (MASS) United States $0.125B 0.00
Sensus Healthcare (SRTS) United States $0.116B 17.19
Spectral Diagnostics (EDTXF) Canada $0.114B 0.00
EDAP TMS S.A (EDAP) France $0.094B 0.00
LENSAR (LNSR) United States $0.086B 0.00
WORK Medical Technology Group (WOK) China $0.079B 0.00
Covalon Technologies (CVALF) Canada $0.076B 0.00
Monogram Orthopaedics (MGRM) United States $0.076B 0.00
Vicarious Surgical (RBOT) United States $0.066B 0.00
Hyperfine (HYPR) United States $0.066B 0.00
EnVVeno Medical (NVNO) United States $0.064B 0.00
InspireMD (NSPR) Israel $0.061B 0.00
Lucid Diagnostics (LUCD) United States $0.057B 0.00
Rapid Micro Biosystems (RPID) United States $0.055B 0.00
Accelerate Diagnostics (AXDX) United States $0.048B 0.00
Envoy Medical (COCH) United States $0.042B 0.00
Biosig Technologies (BSGM) United States $0.038B 0.00
Adagio Medical Holdings (ADGM) United States $0.035B 0.00
Neuronetics (STIM) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.030B 0.00
Precision Optics (POCI) United States $0.030B 0.00
Spectral AI (MDAI) United States $0.026B 0.00
NexGel (NXGL) United States $0.022B 0.00
Baird Medical Investment Holdings (BDMD) $0.020B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.017B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
Autonomix Medical (AMIX) United States $0.012B 0.00
T2 Biosystems (TTOO) United States $0.012B 0.00
PAVmed (PAVM) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
Pixie Dust Technologies (PXDT) Japan $0.007B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00